ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.233,62
-0,04%
Dow Jones
38.390,88
0,73%
Euro vs US Dollar
1,08421
0,10%
Bitcoin
67.461,95
-1,32%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Inspira Technologies Oxy B H N Ltd (IINN)

  7. Inspira Technologies Oxy B H N Ltd (IINN) News

IINN

Inspira Technologies Oxy... (IINN)

Inspira Technologies Oxy B H N Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IINN
DatumZeitQuelleÜberschriftSymbolFirma
30/05/202414h30PR Newswire (US)Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant DevelopmentsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
28/05/202415h25PR Newswire (US)INSPIRA™ ART100 Receives FDA 510(k) ClearanceNASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/05/202415h18PR Newswire (US)Inspira™ Announces Start of Production of the INSPIRA™ ART100NASDAQ:IINNInspira Technologies Oxy B H N Ltd
25/04/202414h00PR Newswire (US)Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100NASDAQ:IINNInspira Technologies Oxy B H N Ltd
16/04/202414h42PR Newswire (US)Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant ProceduresNASDAQ:IINNInspira Technologies Oxy B H N Ltd
10/04/202414h24PR Newswire (US)Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream InfectionsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/04/202414h30PR Newswire (US)Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial WombNASDAQ:IINNInspira Technologies Oxy B H N Ltd
01/04/202414h00PR Newswire (US)Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund ManagerNASDAQ:IINNInspira Technologies Oxy B H N Ltd
25/03/202414h20PR Newswire (US)Inspira™ Technologies Reports Full Year 2023 Financial ResultsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
18/03/202412h00PR Newswire (US)Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American MarketsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
12/03/202413h00PR Newswire (US)Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS IndicatorNASDAQ:IINNInspira Technologies Oxy B H N Ltd
08/03/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
04/03/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
04/03/202415h25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
04/03/202415h20PR Newswire (US)Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within DaysNASDAQ:IINNInspira Technologies Oxy B H N Ltd
27/02/202413h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
27/02/202413h02PR Newswire (US)Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major MilestoneNASDAQ:IINNInspira Technologies Oxy B H N Ltd
27/02/202413h00PR Newswire (US)Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution AgreementsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
22/02/202415h18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
22/02/202413h00PR Newswire (US)Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologiesNASDAQ:IINNInspira Technologies Oxy B H N Ltd
14/02/202415h18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
14/02/202413h30PR Newswire (US)Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery SystemNASDAQ:IINNInspira Technologies Oxy B H N Ltd
12/02/202422h05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
12/02/202422h05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
08/02/202415h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
08/02/202415h00PR Newswire (US)Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART DeviceNASDAQ:IINNInspira Technologies Oxy B H N Ltd
30/01/202414h40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
30/01/202414h30PR Newswire (US)Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART DevicesNASDAQ:IINNInspira Technologies Oxy B H N Ltd
09/01/202415h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
09/01/202414h30PR Newswire (US)Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market OpportunityNASDAQ:IINNInspira Technologies Oxy B H N Ltd
 Showing the most relevant articles for your search:NASDAQ:IINN

Kürzlich von Ihnen besucht

NASDAQ
FTXN
First Trust Nasdaq Oil a...
EU
2824T
2824T
TG
VI9A
Victoria Gold
TG
6RJ
Rocket Lab USA
USOTC
PWBK
Pacific West Bancorp (PK)
TSXV
RVV
Revive Therapeutics
TG
1C1A
Castor Maritime
TSXV
STC
Sangoma Technologies
COIN
PNGUSD
Pangolin
COIN
LDFIETH
Lendefi Token
BIBX
SHIBICUSDT
Shiba Inu Classic
COIN
IREUST
IRE Token
TG
CMN1
Chemring
TG
C8V
Evoke
TG
1KQ
Atlas Pearls
LSE
80MK
Orbit 38
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten